Novel Strategy with Gemcitabine for Advanced Pancreatic Cancer

5-fluorouracil (5-FU) is widely used in chemotherapy for gastric and colorectal cancer, but gemcitabine (GEM), and not 5-FU, is approved as a standard drug for use in pancreatic cancer. Interindividual variation in the enzyme activity of the GEM metabolic pathway can affect the extent of GEM metabol...

Descripción completa

Detalles Bibliográficos
Autores principales: Komori, Shuji, Osada, Shinji, Yoshida, Kazuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scholarly Research Network 2011
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3200206/
https://www.ncbi.nlm.nih.gov/pubmed/22091436
http://dx.doi.org/10.5402/2011/936893

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3200206/
https://www.ncbi.nlm.nih.gov/pubmed/22091436
http://dx.doi.org/10.5402/2011/936893

Ejemplares similares